---

$1.49

-1.5900 ( -51.60% ) 292.4K

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212.

Open	$1.49
Previous Close	$3.08
Volume	292.4K
Market Cap	$391.75M
Day Range	$1.22 - $1.72
52 Week Range	$1.22 - $4.98
Shares Outstanding	127.19M
Change %	-51.60%
Net Change	▼ -1.5900
Insider Ownership	-0.03%
Exchange	NYSE
Sector	Miscellaneous
Industry	None
IPO Year	2020
Country	United States
Underwriter	IPO Intelligence Only

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2024-02-09	Buy	56900.00	Redmile Group, LLC